2018 American Transplant Congress
Long-Term Outcomes of Graft Function in Elderly Kidney Transplant Recipients
Henry Ford Transplant Institute, Detroit, MI.
Purpose: To compare and evaluate 5-year outcomes of graft function for younger (Y) versus elderly (E) kidney transplant recipients (KTR).Introduction: As the number of elderly…2018 American Transplant Congress
Pancreas Transplant Alone (PTA) Outcome is Best in Brittle Diabetic Patients without Advanced Nephropathy
1SUNY Upstate Medical University, Syracuse, NY; 2SUNY Downstate Medical Center, Brooklyn, NY.
Introduction: Although the overall number of pancreas transplants in combination with or after a kidney transplant have declined, the number of PTA has remained relatively…2018 American Transplant Congress
Prevention of Hepatitis B Virus Reactivation in HBsAg-Positive Renal Transplant Recipients with Rituximab Treatment
Background: The risk of Hepatitis B virus (HBV) reactivation under immunosuppressant has been well known. Hepatitis B virus reactivation increase patient mortality and graft failure…2018 American Transplant Congress
Efficacy and Safety of Acute Antibody Rejection Treatment in Pediatric Kidney Transplant Recipients
Purpose: Evaluate the efficacy and safety of acute antibody mediated rejection (AMR) treatment modalities in pediatric kidney transplant recipients (KTR).Methods: A single-center retrospective chart review…2018 American Transplant Congress
The Efficacy of Low Dose Steroid Therapy for Postoperative Hyperbilirubinemia in Liver Transplant Recipients: A Prospective Randomized Controlled Trial
Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Background: Hyperbilirubinemia is a common but reversible event after liver transplantation . Steroids is a widely used anti-inflammatory agent, which may help improve allograft function,…2018 American Transplant Congress
Comparison of Outcome in Liver Transplant Patients with Renal Insufficiency and Intraoperative CVVH
Transplant Institute, Henry Ford Health System, Detroit, MI.
Background: Intraoperative continuous veno-venous hemofiltration (CVVH) is an important tool to manage liver transplant (LT) patients with renal insufficiencies. Methods: All LT patients with renal…2018 American Transplant Congress
Declining Number of Pancreas after Kidney Transplants Despite Significant Improvement in Outcome
1SUNY Downstate Medical Center, Brooklyn, NY; 2SUNY Upstate Medical University, Syracuse, NY.
Introduction: The number of whole organ pancreas transplants declined significantly over the past 15 years. The largest decrease was seen in pancreas after kidney (PAK)…2018 American Transplant Congress
Metabolic Complications 10-Years after Kidney Transplant
Background: Improving long-term outcomes is an important but unmet need after kidney transplant. Protocol renal allograft biopsies taken 10-years after transplant frequently show diabetic nephropathy…2018 American Transplant Congress
The Novel Polymer Pro-Drug APP-103 Reduces I/R Injury and Improves Graft Function in a Pre-Clinical Renal Transplant Model
Purpose: Ischemia-reperfusion injury (IRI) is the strongest non-HLA factor that augments allogenicity of transplanted organs. Damage subsequent to IRI is critically linked to an abundance…2018 American Transplant Congress
Adjunctive Corticosteroid Immunosuppression Improves Hyperbilirubinemia Following Liver Transplantation (OLT)
Drexel University, Philadelphia.
Background: Deceased donor orthotopic liver transplantation (OLT) can result in significant delayed function, manifesting as protracted hyperbilirubinemia, depending on the intensity of the ischemia/reperfusion injury…
- « Previous Page
- 1
- …
- 37
- 38
- 39
- 40
- 41
- …
- 64
- Next Page »